Ionis Pharmaceuticals, Inc. today announced that it has entered into a license agreement under which Sobi® receives exclusive rights in countries outside the U.S., Canada and China to commercialize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback